newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests

PARSIPPANY, NJ, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX:IDXG) ("Interpace" or the "Company") a leader in enabling personalized medicine, announced today that it was terminating its previously announced rights offering and t